» Articles » PMID: 19399503

Higher Genetic Susceptibility to Inflammation in Mild Disease Activity of Systemic Lupus Erythematosus

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2009 Apr 29
PMID 19399503
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In order to test the hypothesis that stratification of Mexican Modification of the Systemic Lupus Erythematosus Disease Activity Index (MEX-SLEDAI) simplifies the genetic study of SLE, we evaluated the genetic susceptibility to inflammation and defects in clearance of immune complexes among SLE patients in Taiwan. SLE phenotypes were stratified according to the MEX-SLEDAI scores into two subgroups (<or=10 and >10), and then according to renal disorder and neurological disorder, aiming to minimize any loss of power associated with disease heterogeneity. Upon stratification, IL1-beta polymorphism and LTA were significantly associated with SLE within the MEX-SLEDAI <or=10 subgroup. When SLE patients were classified into two subgroups with or without renal disorder to stratify the genetic study, we could find that the stratification with renal disorder could partially confirm the hypothesis that stratification of MEX-SLEDAI score simplifies the genetic study of complex diseases such as SLE. So we concluded that in the mild disease state of SLE, stratification of disease phenotypes, especially IL1-beta and LTA, according to MEX-SLEDAI scores could reveal new associations between candidate genes and disease activity index of SLE.

Citing Articles

Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease.

Duraes C, Moreira C, Alvelos I, Mendes A, Santos L, Machado J PLoS One. 2014; 9(8):e105492.

PMID: 25127106 PMC: 4134306. DOI: 10.1371/journal.pone.0105492.


Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus.

Tahmasebi Z, Akbarian M, Mirkazemi S, Shahlaee A, Alizadeh Z, Amirzargar A Rheumatol Int. 2013; 33(10):2591-6.

PMID: 23722873 DOI: 10.1007/s00296-013-2784-2.

References
1.
Grennan D, Parfitt A, Manolios N, Huang Q, Hyland V, Dunckley H . Family and twin studies in systemic lupus erythematosus. Dis Markers. 1997; 13(2):93-8. View

2.
Tsokos G . Systemic lupus erythematosus. A disease with a complex pathogenesis. Lancet. 2002; 358 Suppl:S65. DOI: 10.1016/s0140-6736(01)07077-5. View

3.
Haga H, Brun J, Rekvig O, Wetterberg L . Seasonal variations in activity of systemic lupus erythematosus in a subarctic region. Lupus. 1999; 8(4):269-73. DOI: 10.1191/096120399678847858. View

4.
Liang M, Socher S, Larson M, Schur P . Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989; 32(9):1107-18. DOI: 10.1002/anr.1780320909. View

5.
Di Giovine F, Takhsh E, Blakemore A, Duff G . Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet. 1992; 1(6):450. DOI: 10.1093/hmg/1.6.450. View